Chemistry:CT-4201

From HandWiki

CT-4201 is a serotonergic psychedelic which is under development for the treatment of major depressive disorder.[1][2][3] It is a prodrug of the tryptamine psychedelic psilocin that is said to have improved pharmacokinetic properties compared to psilocybin, the primary active constituent of psilocybin-containing mushrooms.[1][2][3][4][5] CT-4201 is being developed by CaaMTech.[1][2][3] As of November 2024, it is in the preclinical research stage of development.[1][2]

See also

References